Drug regulator okays psoriasis injection for limited use in treating COVID-19 patients
Posted by
www.biotecnika.org
Considering the unmet medical needs to treat COVID-19, Drugs
Controller General of India Dr V G Somani approved monoclonal antibody
injection Itolizumab for restricted emergency use for the treatment of
'cytokine' release syndrome in moderate to severe acute respiratory
distress syndrome patients due to COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-regulator-okays-psoriasis-injection-for-limited-use-in-treating-covid-19-patients/articleshow/76904178.cms
Subscribe to:
Post Comments (Atom)
Post a Comment